Scholarlink

Purpose <p>Sepsis-induced disseminated intravascular coagulation (DIC) is characterized by impaired fibrinolysis, partly due to neutrophil elastase-mediated plasminogen degradation. We aimed to evaluate whether plasminogen supplementation could restore fibrinolytic capacity in patients with sepsis-induced coagulopathy and in a murine model of septic DIC.</p> Methods <p>60 patients with sepsis-induced coagulopathy were randomized to receive 12&#xa0;mL/kg of placebo (NaCl 0.9%) or OctaplasLG®, a pathogen-inactivated pooled human plasma containing 2&#xa0;µM plasminogen. Pre- and post-infusion levels of functional plasminogen, plasmin generation, and fibrinolysis markers (plasmin–antiplasmin complexes, plasminogen activator inhibitor-1, and tissue-type plasminogen activator) were measured. In parallel, in a sepsis-induced DIC model, transgenic TM<sup>pro/pro</sup> mice received either purified plasminogen or placebo. Functional plasminogen levels and plasmin generation were assessed via enzymatic assays.</p> Results <p>In patients, baseline plasminogen and plasmin generation were significantly lower than in healthy controls. OctaplasLG® significantly increased functional plasminogen (+ 46&#xa0;nM [−96; 118] vs. −84 [−180; 27] nM, <i>p</i> &lt; 0.05) and improved plasmin generation (0.12 [−0.25; 1.27] vs. −0.36 [−1.58; 0.12] fmol, <i>p</i> &lt; 0.05). No changes were observed in plasmin–antiplasmin, plasminogen activator inhibitor-1, or tissue-type plasminogen activator levels. A non-significant trend toward reduced mortality was noted in patients receiving OctaplasLG® (42.3% vs. 60.0%).</p> <p>Septic DIC-mice also exhibited reduced functional plasminogen (100 [66–126] vs. 295 [268–343] nM) and impaired plasmin generation (1.8 [1.4–2.1] vs. 3.0 [2.8–3.3] fmol, <i>p</i> &lt; 0.05), which were restored after plasminogen supplementation (plasminogen: 346 [287; 360] nM; plasmin generation: 4.1 [3.7; 5.5] fmol).</p> Conclusion <p>Plasminogen supplementation restores fibrinolytic capacity, supporting its therapeutic potential in sepsis-induced DIC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Plasminogen supplementation reverses fibrinolytic insufficiency in sepsis-induced disseminated intravascular coagulation: a pilot study

  • 期刊论文

  • 发表日期：

    2026年2月25日

查看全文
  • Marine Tschirhart,
  • Anaïs Curtiaud,
  • Ramy Abou Rjeily,
  • Hamid Merdji,
  • Julien Demiselle,
  • François Severac,
  • Daniel Guerin,
  • Micael Caçao,
  • Fatiha El Ghazouani,
  • Eduardo Angles-Cano,
  • Florence Toti,
  • Ferhat Meziani,
  • Julie Helms

摘要

Purpose

Sepsis-induced disseminated intravascular coagulation (DIC) is characterized by impaired fibrinolysis, partly due to neutrophil elastase-mediated plasminogen degradation. We aimed to evaluate whether plasminogen supplementation could restore fibrinolytic capacity in patients with sepsis-induced coagulopathy and in a murine model of septic DIC.

Methods

60 patients with sepsis-induced coagulopathy were randomized to receive 12 mL/kg of placebo (NaCl 0.9%) or OctaplasLG®, a pathogen-inactivated pooled human plasma containing 2 µM plasminogen. Pre- and post-infusion levels of functional plasminogen, plasmin generation, and fibrinolysis markers (plasmin–antiplasmin complexes, plasminogen activator inhibitor-1, and tissue-type plasminogen activator) were measured. In parallel, in a sepsis-induced DIC model, transgenic TMpro/pro mice received either purified plasminogen or placebo. Functional plasminogen levels and plasmin generation were assessed via enzymatic assays.

Results

In patients, baseline plasminogen and plasmin generation were significantly lower than in healthy controls. OctaplasLG® significantly increased functional plasminogen (+ 46 nM [−96; 118] vs. −84 [−180; 27] nM, p < 0.05) and improved plasmin generation (0.12 [−0.25; 1.27] vs. −0.36 [−1.58; 0.12] fmol, p < 0.05). No changes were observed in plasmin–antiplasmin, plasminogen activator inhibitor-1, or tissue-type plasminogen activator levels. A non-significant trend toward reduced mortality was noted in patients receiving OctaplasLG® (42.3% vs. 60.0%).

Septic DIC-mice also exhibited reduced functional plasminogen (100 [66–126] vs. 295 [268–343] nM) and impaired plasmin generation (1.8 [1.4–2.1] vs. 3.0 [2.8–3.3] fmol, p < 0.05), which were restored after plasminogen supplementation (plasminogen: 346 [287; 360] nM; plasmin generation: 4.1 [3.7; 5.5] fmol).

Conclusion

Plasminogen supplementation restores fibrinolytic capacity, supporting its therapeutic potential in sepsis-induced DIC.